Venor Pharma Limited Lorazepam Export Data — India (DGFT 2022–2026)

Name: Venor Pharma Limited Lorazepam Export Records India — #3 Exporter, 3 Shipments, $150.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Lorazepam

India Pharmaceutical Trade Intelligence

$2.5M24 Suppliers21 CountriesHS 30049099

ExportsIndia → UNITED STATES45.6%India → SRI LANKA13.4%

ImportsUNITED STATES → India$34.1K GERMANY → India$26.3K

#1 Supplier: APL HEALTHCARE #1 Buyer: XXROBXXDO XXARMXXUSAXX

Venor Pharma Limited — Lorazepam Exporter #3 | $150.0K Trade Value | TransData Nexus | TransData Nexus

Venor Pharma Limited — Lorazepam Exporter Profile

Indian Pharmaceutical Exporter · #3 for Lorazepam · $150.0K export value · DGFT Verified

Venor Pharma Limited is the #3 Indian exporter of Lorazepam with $150.0K in export value and 3 verified shipments. Venor Pharma Limited holds a 6.0% market share in Lorazepam exports across 3 countries. The company exports 9 pharmaceutical products worth $8.6M across 4 therapeutic categories.

Venor Pharma Limited — Lorazepam Export Profile: Buyers & Destinations

Venor Pharma Limited Lorazepam export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Lorazepam?

Country	Value	Shipments	Share
UNITED STATES	$1.1M	23	50.5%
UNITED KINGDOM	$336.0K	28	14.8%
FINLAND	$282.4K	18	12.4%
SWITZERLAND	$132.8K	4

Who Are the Top Buyers of Lorazepam from India?

Buyer	Country	Value	Orders
XXROBXXDO XXARMXXUSAXX INXX	UNITED STATES	$454.5K	10
AUROBINDO PHARMA USA INC	UNITED STATES	$400.0K	8
ORION CORPORATION	FINLAND	$260.6K	14
GENESIS PHARMACEUTICALS LIMITED	UNITED KINGDOM	$176.4K	10
SPIRIG HEALTHCARE AG	SWITZERLAND	$132.8K	4
GENESIS PHARMACEUTICALS LIMITED.	UNITED KINGDOM	$113.7K	10
ANIP ACQUISTION COMPANY	UNITED STATES	$100.0K	2
ESPARMA PHARMA SERVICES GMBH	GERMANY	$79.9K	3
THE PURCHASE MANAGER	UNITED STATES	$66.7K	2
ORION CORPORATION,	FINLAND	$21.8K	2

India's Lorazepam is purchased by 46 buyers worldwide. The top buyer is XXROBXXDO XXARMXXUSAXX INXX (UNITED STATES), followed by AUROBINDO PHARMA USA INC and ORION CORPORATION.

How Does Venor Pharma Limited Compare to Nearest Lorazepam Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	ESJAY PHARMA PRIVATE LIMITED	$200.0K	4	1	$50.0K
5	J B CHEMICALS AND PHARMACEUTICALS LIMITED	$156.3K	19	2	$8.2K
3	VENOR PHARMA LIMITED ★	$150.0K	3	3	$50.0K
6	J B CHEMICALS PHARMACEUTICALS LIMITED	$133.9K	5	1	$26.8K
7	CENTAUR PHARMACEUTICALS PVT LTD	$81.2K	4	2	$20.3K

Venor Pharma Limited ranks #3 among 24 Indian Lorazepam exporters. Average shipment value of $50.0K compared to the market average of $91.7K. The closest competitors by value are ESJAY PHARMA PRIVATE LIMITED and J B CHEMICALS AND PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Lorazepam Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	22	17.6%
NHAVA SHEVA SEA (INNSA1)	16	12.8%
JNPT/ NHAVA SHEVA SEA	13	10.4%
CHENNAI AIR CARGO ACC (INMAA4)	11	8.8%
APIIC LIMITED -NAIDUPETA SEZ	11	8.8%
JNPT	7	5.6%
Naidupeta Apiic	5	4.0%
DELHI AIR CARGO ACC (INDEL4)	4	3.2%

Geopolitical & Trade Policy Impact on Venor Pharma Limited's Lorazepam Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Venor Pharma. The escalation of conflicts in the Middle East, particularly the Red Sea crisis, has led to disruptions in key shipping routes. Major carriers have suspended or restricted transits through the Strait of Hormuz and the Red Sea–Suez Canal corridor, resulting in extended transit times by 10–20 days and increased freight rates by 40–50% on India–Europe routes. (livemint.com) These disruptions are particularly concerning for time-sensitive pharmaceutical shipments, potentially affecting the timely delivery of products like Diazepam and Fentanyl.

In the United States, recent trade policies have introduced additional complexities. The imposition of a 25% reciprocal tariff on Indian imports, effective August 2025, and the subsequent increase to a 50% tariff linked to India's energy trade decisions, have raised concerns about the cost competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org) While pharmaceuticals have been largely exempt from these tariffs, the potential for future policy shifts necessitates vigilance.

The European Union's implementation of the Falsified Medicines Directive (FMD) has also impacted Indian exporters. Compliance with stringent serialization and traceability requirements has increased operational costs. For companies like Venor Pharma, ensuring adherence to these regulations is crucial to maintain market access and competitiveness in the EU.

Venor Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA, WHO, and EU authorities enforcing stringent Good Manufacturing Practice (GMP) standards. Instances such as the FDA's warning letter and import alert issued to Viatris' facility in Indore, India, in December 2024, highlight the critical importance of compliance. (en.wikipedia.org) For Venor Pharma, maintaining impeccable quality standards and regulatory compliance is essential to avoid similar setbacks and to sustain its export operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Lorazepam shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venor Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 21+ countries, 46+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Lorazepam

Lorazepam

Venor Pharma Limited — Lorazepam Exporter Profile

Venor Pharma Limited — Lorazepam Export Profile: Buyers & Destinations

Where Does India Export Lorazepam?

Who Are the Top Buyers of Lorazepam from India?

What Is India's Total Lorazepam Export Value and How Much Does Venor Pharma Limited Contribute?

What Is the Average Shipment Value for Venor Pharma Limited's Lorazepam Exports?

How Does Venor Pharma Limited Compare to Other Indian Lorazepam Exporters?

Regulatory Requirements: Exporting Lorazepam to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Venor Pharma Limited Compare to Nearest Lorazepam Exporters?

Which Indian Ports Ship Lorazepam Exports?

What Other CNS & Psychiatric Products Does Venor Pharma Limited Export?

Geopolitical & Trade Policy Impact on Venor Pharma Limited's Lorazepam Exports

Venor Pharma Limited — Regulatory Compliance & Quality Standards

About Venor Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Lorazepam Export Data from Venor Pharma Limited

Lorazepam Stats

Company Overview

Top Products by Venor Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source